BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 35408935)

  • 1. TKTL1 Knockdown Impairs Hypoxia-Induced Glucose-6-phosphate Dehydrogenase and Glyceraldehyde-3-phosphate Dehydrogenase Overexpression.
    Baptista I; Karakitsou E; Cazier JB; Günther UL; Marin S; Cascante M
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene Suppression of Transketolase-Like Protein 1 (TKTL1) Sensitizes Glioma Cells to Hypoxia and Ionizing Radiation.
    Heller S; Maurer GD; Wanka C; Hofmann U; Luger AL; Bruns I; Steinbach JP; Rieger J
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30044385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for transketolase-like TKTL1 flux in CHO cells based on parallel labeling experiments and (13)C-metabolic flux analysis.
    Ahn WS; Crown SB; Antoniewicz MR
    Metab Eng; 2016 Sep; 37():72-78. PubMed ID: 27174718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transketolase-like protein 1 (TKTL1) is required for rapid cell growth and full viability of human tumor cells.
    Xu X; Zur Hausen A; Coy JF; Löchelt M
    Int J Cancer; 2009 Mar; 124(6):1330-7. PubMed ID: 19065656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation.
    Tang YC; Hsiao JR; Jiang SS; Chang JY; Chu PY; Liu KJ; Fang HL; Lin LM; Chen HH; Huang YW; Chen YT; Tsai FY; Lin SF; Chuang YJ; Kuo CC
    Theranostics; 2021; 11(11):5232-5247. PubMed ID: 33859744
    [No Abstract]   [Full Text] [Related]  

  • 6. Elevated activity of the oxidative and non-oxidative pentose phosphate pathway in (pre)neoplastic lesions in rat liver.
    Frederiks WM; Vizan P; Bosch KS; Vreeling-Sindelárová H; Boren J; Cascante M
    Int J Exp Pathol; 2008 Aug; 89(4):232-40. PubMed ID: 18422600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of TKTL1 additively complements cisplatin-induced cytotoxicity in nasopharyngeal carcinoma cells by regulating the levels of NADPH and ribose-5-phosphate.
    Dong Y; Wang M
    Biomed Pharmacother; 2017 Jan; 85():672-678. PubMed ID: 27916418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of IRE1 modifies hypoxic regulation of G6PD, GPI, TKT, TALDO1, PGLS and RPIA genes expression in U87 glioma cells.
    Minchenko OH; Garmash IA; Minchenko DO; Kuznetsova AY; Ratushna OO
    Ukr Biochem J; 2017; 89(1):38-49. PubMed ID: 29236388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastasis is promoted by a bioenergetic switch: new targets for progressive renal cell cancer.
    Langbein S; Frederiks WM; zur Hausen A; Popa J; Lehmann J; Weiss C; Alken P; Coy JF
    Int J Cancer; 2008 Jun; 122(11):2422-8. PubMed ID: 18302154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of TKTL1 by siRNA inhibits proliferation of human gastric cancer cells in vitro and in vivo.
    Yuan W; Wu S; Guo J; Chen Z; Ge J; Yang P; Hu B; Chen Z
    Cancer Biol Ther; 2010 May; 9(9):710-6. PubMed ID: 20200485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transketolase in human Müller cells is critical to resist light stress through the pentose phosphate and NRF2 pathways.
    Chen Y; Zhang T; Zeng S; Xu R; Jin K; Coorey NJ; Wang Y; Wang K; Lee SR; Yam M; Zhu M; Chang A; Fan X; Zhang M; Du J; Gillies MC; Zhu L
    Redox Biol; 2022 Aug; 54():102379. PubMed ID: 35779441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-yield anaerobic succinate production by strategically regulating multiple metabolic pathways based on stoichiometric maximum in Escherichia coli.
    Meng J; Wang B; Liu D; Chen T; Wang Z; Zhao X
    Microb Cell Fact; 2016 Aug; 15(1):141. PubMed ID: 27520031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transketolase-like 1 ectopic expression is associated with DNA hypomethylation and induces the Warburg effect in melanoma cells.
    Jayachandran A; Lo PH; Chueh AC; Prithviraj P; Molania R; Davalos-Salas M; Anaka M; Walkiewicz M; Cebon J; Behren A
    BMC Cancer; 2016 Feb; 16():134. PubMed ID: 26907172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A key role for transketolase-like 1 in tumor metabolic reprogramming.
    Diaz-Moralli S; Aguilar E; Marin S; Coy JF; Dewerchin M; Antoniewicz MR; Meca-Cortés O; Notebaert L; Ghesquière B; Eelen G; Thomson TM; Carmeliet P; Cascante M
    Oncotarget; 2016 Aug; 7(32):51875-51897. PubMed ID: 27391434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nrf2-driven TERT regulates pentose phosphate pathway in glioblastoma.
    Ahmad F; Dixit D; Sharma V; Kumar A; Joshi SD; Sarkar C; Sen E
    Cell Death Dis; 2016 May; 7(5):e2213. PubMed ID: 27148686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of neuronal differentiation by carbon monoxide: Role of pentose phosphate pathway.
    Almeida AS; Soares NL; Sequeira CO; Pereira SA; Sonnewald U; Vieira HLA
    Redox Biol; 2018 Jul; 17():338-347. PubMed ID: 29793167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A δ38 deletion variant of human transketolase as a model of transketolase-like protein 1 exhibits no enzymatic activity.
    Schneider S; Lüdtke S; Schröder-Tittmann K; Wechsler C; Meyer D; Tittmann K
    PLoS One; 2012; 7(10):e48321. PubMed ID: 23118983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose is necessary for stabilization of hypoxia-inducible factor-1alpha under hypoxia: contribution of the pentose phosphate pathway to this stabilization.
    Osada-Oka M; Hashiba Y; Akiba S; Imaoka S; Sato T
    FEBS Lett; 2010 Jul; 584(14):3073-9. PubMed ID: 20621833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic reprogramming and redox adaptation in sorafenib-resistant leukemia cells: detected by untargeted metabolomics and stable isotope tracing analysis.
    You X; Jiang W; Lu W; Zhang H; Yu T; Tian J; Wen S; Garcia-Manero G; Huang P; Hu Y
    Cancer Commun (Lond); 2019 Apr; 39(1):17. PubMed ID: 30947742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma.
    Du D; Liu C; Qin M; Zhang X; Xi T; Yuan S; Hao H; Xiong J
    Acta Pharm Sin B; 2022 Feb; 12(2):558-580. PubMed ID: 35256934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.